NM_001365276.2:c.12058+11G>A
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001365276.2(TNXB):c.12058+11G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.011 ( 13 hom., cov: 15)
Exomes 𝑓: 0.016 ( 211 hom. )
Consequence
TNXB
NM_001365276.2 intron
NM_001365276.2 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.73
Publications
0 publications found
Genes affected
TNXB (HGNC:11976): (tenascin XB) This gene encodes a member of the tenascin family of extracellular matrix glycoproteins. The tenascins have anti-adhesive effects, as opposed to fibronectin which is adhesive. This protein is thought to function in matrix maturation during wound healing, and its deficiency has been associated with the connective tissue disorder Ehlers-Danlos syndrome. This gene localizes to the major histocompatibility complex (MHC) class III region on chromosome 6. It is one of four genes in this cluster which have been duplicated. The duplicated copy of this gene is incomplete and is a pseudogene which is transcribed but does not encode a protein. The structure of this gene is unusual in that it overlaps the CREBL1 and CYP21A2 genes at its 5' and 3' ends, respectively. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
TNXB Gene-Disease associations (from GenCC):
- Ehlers-Danlos syndromeInheritance: AR Classification: DEFINITIVE Submitted by: G2P
- Ehlers-Danlos syndrome due to tenascin-X deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Illumina, PanelApp Australia, Orphanet
- familial vesicoureteral refluxInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- vesicoureteral reflux 8Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 6-32042688-C-T is Benign according to our data. Variant chr6-32042688-C-T is described in CliVar as Likely_benign. Clinvar id is 261118.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-32042688-C-T is described in CliVar as Likely_benign. Clinvar id is 261118.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-32042688-C-T is described in CliVar as Likely_benign. Clinvar id is 261118.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-32042688-C-T is described in CliVar as Likely_benign. Clinvar id is 261118.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-32042688-C-T is described in CliVar as Likely_benign. Clinvar id is 261118.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-32042688-C-T is described in CliVar as Likely_benign. Clinvar id is 261118.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-32042688-C-T is described in CliVar as Likely_benign. Clinvar id is 261118.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-32042688-C-T is described in CliVar as Likely_benign. Clinvar id is 261118.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0113 (1332/117466) while in subpopulation NFE AF = 0.0182 (1012/55542). AF 95% confidence interval is 0.0173. There are 13 homozygotes in GnomAd4. There are 608 alleles in the male GnomAd4 subpopulation. Median coverage is 15. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 13 AR,AD gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TNXB | NM_001365276.2 | c.12058+11G>A | intron_variant | Intron 39 of 43 | ENST00000644971.2 | NP_001352205.1 | ||
TNXB | NM_001428335.1 | c.12799+11G>A | intron_variant | Intron 40 of 44 | NP_001415264.1 | |||
TNXB | NM_019105.8 | c.12052+11G>A | intron_variant | Intron 39 of 43 | NP_061978.6 | |||
TNXB | NM_032470.4 | c.1345+11G>A | intron_variant | Intron 8 of 12 | NP_115859.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0114 AC: 1332AN: 117350Hom.: 13 Cov.: 15 show subpopulations
GnomAD3 genomes
AF:
AC:
1332
AN:
117350
Hom.:
Cov.:
15
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0102 AC: 1351AN: 133078 AF XY: 0.0102 show subpopulations
GnomAD2 exomes
AF:
AC:
1351
AN:
133078
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0159 AC: 17226AN: 1086778Hom.: 211 Cov.: 16 AF XY: 0.0153 AC XY: 8365AN XY: 546304 show subpopulations
GnomAD4 exome
AF:
AC:
17226
AN:
1086778
Hom.:
Cov.:
16
AF XY:
AC XY:
8365
AN XY:
546304
show subpopulations
African (AFR)
AF:
AC:
58
AN:
26902
American (AMR)
AF:
AC:
56
AN:
35068
Ashkenazi Jewish (ASJ)
AF:
AC:
21
AN:
23116
East Asian (EAS)
AF:
AC:
0
AN:
33846
South Asian (SAS)
AF:
AC:
3
AN:
74704
European-Finnish (FIN)
AF:
AC:
1144
AN:
36160
Middle Eastern (MID)
AF:
AC:
0
AN:
3570
European-Non Finnish (NFE)
AF:
AC:
15465
AN:
805444
Other (OTH)
AF:
AC:
479
AN:
47968
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
796
1592
2387
3183
3979
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
468
936
1404
1872
2340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0113 AC: 1332AN: 117466Hom.: 13 Cov.: 15 AF XY: 0.0108 AC XY: 608AN XY: 56140 show subpopulations
GnomAD4 genome
AF:
AC:
1332
AN:
117466
Hom.:
Cov.:
15
AF XY:
AC XY:
608
AN XY:
56140
show subpopulations
African (AFR)
AF:
AC:
80
AN:
29744
American (AMR)
AF:
AC:
21
AN:
12084
Ashkenazi Jewish (ASJ)
AF:
AC:
3
AN:
2968
East Asian (EAS)
AF:
AC:
0
AN:
3682
South Asian (SAS)
AF:
AC:
1
AN:
3180
European-Finnish (FIN)
AF:
AC:
208
AN:
7896
Middle Eastern (MID)
AF:
AC:
0
AN:
270
European-Non Finnish (NFE)
AF:
AC:
1012
AN:
55542
Other (OTH)
AF:
AC:
7
AN:
1470
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
58
116
174
232
290
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.